Last reviewed · How we verify

NCT05082220

Analysis of Spread Level During Thoracic Erector Spinae Block

Completed NA Last updated 27 December 2022
What this trial tests

NA trial testing Erector spinae plane block in Pain in 157 participants. Completed in 30 October 2022.

Timeline
21 February 2022
Primary endpoint
30 October 2022
30 October 2022

Quick facts

Lead sponsorKeimyung University Dongsan Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment157
Start date21 February 2022
Primary completion30 October 2022
Estimated completion30 October 2022
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Keimyung University Dongsan Medical Center

Who can join

Adults 20 to 80, any sex, with Pain or Radiculopathy, Cervical. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of this study was to identify the ESPB spread level in the craniocaudal direction when performed at the T2 level. The secondary purpose was to determine the incidence of spread into epidural, paravertebral, intercostal, and intravascular injections with ESPB

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of postoperative back pain between paramedian and midline approach for thoracic epidural anesthesia.
    Hong JH, Cho EY, Shim JW, Park KB. · · 2022 · cited 2× · PMID 35918866 · DOI 10.17085/apm.22139

Verify or expand the search:

Other trials of Erector spinae plane block

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Keimyung University Dongsan Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05082220.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing